Abstract
l-Asparaginase (E.C. 3.5.1.1) is used as an anti-neoplastic drug in the treatment of acute lymphoblastic leukemia. l-Asparaginase from Pseudomonas fluorescens was cloned and overexpressed in E. coli BL21. The Enzyme was found to be a Fusion protein-asparaginase complex which was given a lysozyme treatment and sonication, and then was purified in a Sepharose 6B column. The enzymatic properties of the recombinant enzyme were studied and the kinetic parameters were determined with kilometre of 109.99 mM and V max of 2.88 µM/min. Recombinant enzyme showed pH optima at 6.3 and temperature optima at 34 °C. Asp gene was successfully cloned into E. coli BL21 which produced high level of asparaginase intracellularly with 85.25 % recovery of enzyme with a specific activity of 0.94 IU/mg protein. The enzyme was a tetramer with molecular weight of approximately 141 kDa.
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Introduction
l-Asparaginase enzymes (l-asparagine amidohydrolase) catalyse the hydrolysis of l-asparagine to l-aspartate and ammonia, and to a lesser extent, the hydrolysis of l-glutamine to l-glutamate (Ebrahiminezhad et al. 2011). Bacterial l-asparaginase are of two types: type 1 and type 2; type 2 showed antitumor activity because of which interest in l-asparaginase arose (Lee et al. 1989). Normal cells can synthesize l-asparaginase and because of their ability to produce this amino acid, normal cells are protected from l-asparaginase starvation unlike tumor cells which are dependent on an exogenous supply (Oza et al. 2011). Depletion of the circulating l-asparaginase by l-asparaginase enzyme results in anti-neoplastic activity. However, Escherichia coli and Erwinia sp. enzymes have been frequently used in cancer therapy (Avramis and Panosyan 2005).
l-Asparaginase from bacterial origin can cause hypersensitivity in the long term used, leading to allergic reactions and anaphylaxis. The toxicity is partially attributable to the glutaminase activity of these enzymes (Oza et al. 2011). l-Asparaginases with high asparaginase activity and negligible glutaminase activity are reported to be less troublesome during the course of antitumor therapy (Hawkins et al. 2004). The search for other asparaginase sources, with new immunological characteristics can lead to enzyme with less adverse effects. Furthermore, new studies have revealed potential application of this enzyme in prevention of acrylamide formation in fried potatoes and similar food products. Therefore, introduction of new fermentation and purification protocols for production of l-asparaginase II will be mandatory to satisfy these demands (Aghaeepoor et al. 2011). So, in this study we will be describing the cloning, expression, purification and characterization of recombinant l-asparaginase from P. fluorescens into E. coli BL21.
Materials and methods
Materials
l-Asparaginase-specific primers used in this study were synthesized by Sigma-Aldrich Co (India). Taq polymerase and dNTPs were procured from Bangalore Genei (India) Pvt. Ltd. and pET101 TOPO vector kit was obtained from Invitrogen (India). l-Asparagine and Lysozyme was obtained from Sisco Research Laboratories Pvt. Ltd, Mumbai. Sonicator used was manufactured by Qsonica and Fermenter was designed and manufactured by CFTRI. E. coli BL21, E. coli DH5α and Pseudomonas fluorescens isolates were precured from CSIR-CFTRI, Mysore.
DNA isolation and synthesis
Pseudomonas fluorescens was inoculated into induced 50 ml broth and was grown overnight followed by centrifuging and washing thoroughly with sterile distilled water to remove all traces of broth and extraneous material. Extraction of DNA was carried out using Lysozyme solution. Sequences homologous to ASP were sought in the NCBI using BLAST. A DNA sequence of l-asparaginase from P. fluorescens (GI no: 255961261) was used for primer synthesis. PCR was used to amplify the full-length DNA. The DNA synthesis was carried out in a total volume of 25 µl, containing 1 µl of DNA templet, 1 µl each of both forward and reverse primer, 0.3 µl taq polymerase, 0.5 µl dNTP mix, 2.5 µl PCR Buffer and 18.7 µl milli q water. The PCR procedure comprised 30 cycles of 30 s at 94 °C, 1 min at 63.6 °C and 30 s at 72 °C. A final extension time at 72 °C for 10 min was performed after the 30 cycles. The resulting PCR amplicon was sequenced.
Cloning of ASP gene
For cloning, the primers were designed in such a manner that they included the CACC sites at 5′ end of the PCR amplicon, so it can be used for TOPO PET101 vector. The forward primer PFVJF3: 5′-CACCATGACATGTGCTTTGAAGAGTTTCGTCCGG-3′ and the reverse primer PFVJR4: 5′-TCAGTATTCCCAGAACATCCGTTGCAGCTC-3′ was used. The resulting amplified PCR amplicon was obtained through PCR with the conditions mentioned above. The amplified product was cloned with the plasmid vector pET101. The cloned vector was transformed to competent E. coli DH5α cells. The transformed E. coli cells were grown into LB agar plate containing 100 µg/ml ampicillin, IPTG and X-gal. The recombinant clones were identified by blue/white selection and grown at 37 °C in 50 ml LB medium containing 100 µg/ml ampicillin. The plasmid was isolated from E. coli DH5α and was used to transform competent E. coli BL21 cells which were screened with blue/white selection.
Pilot fermentation
The cells were grown into LB agar plate containing ampicillin. Scale up of recombinant clones was done for 6 L medium for fermentation in 10 L fermenter. The recombinant clones were grown in LB medium containing ampicillin (100 µg/ml) at fermentation conditions of 37 °C with agitation of 180 rpm and aeration of 2 vvm. Synthesis of asparaginase was induced by the addition of 1 mM IPTG after 6–8 h of growth.
Purification of asparaginase
Purification of asparaginase was done 16 h after induction by IPTG, cells were harvested by centrifugation at 6000g for 3 h. Cells obtained after harvesting were resuspended into 15 mM phosphate buffer with pH 6.3, grounded manually with sterile sand and centrifuged at 10,000g for 15 min at 4 °C. The supernatant was collected and used for purification. The fusion protein purification was done by treatment with 2 mg/ml lysozyme for 2 h and then sonication at 60 % amplitude for 5 min with 30 s burst. After sonication, the extract was centrifuged at 10,000g for 30 min at 4 °C. The extracted solution was then loaded to a pre-equilibrated Sepharose 6B column (1 × 20 cm) with mobile phase 15 mM phosphate buffer with pH 6.3 (Gladilina et al. 2009). The fractions collected (2 ml) were assayed for asparaginase activity. The purified enzyme was dialyzed to remove salt.
Estimation of ASNase activity
Asparaginase assay for native and modified ASNases was performed for the formation of β-aspartylhydroxamate (Ramakrishnan and Joseph 1996). Authentic β-aspartylhydroxamate was employed as a standard. One unit (U) of asparaginase is defined as the amount of enzyme that formed 1 µmol of β-aspartylhydroxamate in 1 min under assay conditions. The specific activity is expressed as U/mg/min of protein. Protein content was measured according to (Bradford 1976) using BSA as a standard.
Kinetic analysis
Determination of kinetic constants
Steady-state kinetic measurements were performed to obtain kinetic constants K m and V max, of the purified l-asparaginase were determined by the method of Lineweaver and Burk (1934) with different concentrations (0.5 mM–1 M) of l-asparagine as a substrate at room temperature using sodium phosphate buffer (15 mM, pH 6.3).
Effect of pH and temperature on enzyme activity
The effect of pH on purified enzyme was investigated in the pH range 5.0–9.0 (using 15 mM sodium acetate buffer for pH 5.0–6.0, sodium phosphate buffer for pH 7.0–8.0 and carbonate-bicarbonate buffer for pH 9.0). The enzyme was incubated in these buffers for 1 h and the assay was carried out as given above. The optimal temperature for l-asparaginase activity of the purified enzyme was measured by incubating the enzyme-substrate mixtures for 1 h at various temperatures (8–45 °C) at pH 6, and the liberated ammonia and β-aspartylhydroxamate were measured.
Effect of macro-nutrients on l-asparaginase activity
Macro-nutrients including sodium (NaCl), potassium (KCl), magnesium (MgCl2), iron (FeCl3) and calcium chloride (CaCl2) at 1 mM were evaluated for their effect on l-asparaginase activity by incubating the enzyme at optimum pH and temperature for 1 h, and then ASNase activity was assayed by estimating the product formed at 500 nm. Relative activities were calculated and compared with the native ASNase.
Thermal stability and half-life of cloned ASNase
To study the thermal stability of ASNase, the cloned enzyme was incubated at 28 °C (room temperature) and 37 °C in the absence of the substrate. At periodic intervals, aliquots were withdrawn and assay was performed as described above. The residual activity was expressed as percent of the initial activity. The inactivation rate constants (k d) were calculated from slopes of a semi-logarithmic plot of residual activity versus time, and apparent half lives were estimated using Eq. (1). The time where the residual activity reaches 50 % is known as the half-life (Kishore et al. 2014).
Results
Cloning and expression of ASP gene
The DNA yield obtained through Lysozyme method from Pseudomonas fluorescens was of good quantity and suitable for further use. The DNA was used as a template for synthesizing and amplifying desired l-asparaginase DNA by PCR and the PCR amplicon was purified. To select the required expression product, pET101 vector was chosen. The amplified product was checked for the presence of gene of interest by using the desired primers by PCR. The fusion plasmid with gene was used to initially transform into E. coli DH5α. The plasmid from E. coli DH5α cells was purified and used to transform expression host E. coli BL21. Cell-free extract of the E. coli BL21 gave fusion protein-asparaginase complex with a total protein content of 2.16 mg protein/ml.
Purification of asparaginase
Fusion protein-asparaginase complex was given a lysozyme treatment and sonication, and was then purified in a one-step procedure (Table 1). In the purification scheme, a Sepharose 6B column was used. Pre-treated enzyme extract was applied directly to the Sepharose column equilibrated with 15 mM phosphate buffer pH 6.3. The enzyme was obtained as per size exclusion and was eluted. The asparaginase activity was shown by fractions with a specific activity of 11.6 IU/mg protein. The purity of the final asparaginase was evaluated by SDS-PAGE, which showed that the Asparaginase is a tetramer with molecular weight of the cloned product around 141 kDa (Fig. 1).
Kinetic analysis results
Determination of kinetic constants
Steady-state kinetic measurements were performed according to “Materials and methods”, Michaelis–Menten plot was done (Fig. 2) and kinetic constants K m was found to be 109.99 mM and V max was 2.88 µM/min.
Effect of pH on enzyme activity
Since microorganisms are sensitive to the concentration of hydrogen ions present in the medium, pH is considered as an important factor that determines the growth, morphology and product formation. Effect of pH was studied in range of 5–9 according to “Materials and methods” and it was observed that the optimum pH was 6.3 (Fig. 3).
Effect of temperature on enzyme activity
After obtaining the optimum pH for enzyme, the experiments were run at phosphate buffer pH of 6.3 at different temperatures from 8 to 45 °C according to “Materials and methods” and it was observed that enzyme activities at 8 °C was low, and there was a gradual increase in activity with increase in temperature up to 34 °C which was found to be optimum temperature (Fig. 4). Further rise in temperature would have led to the degradation of enzyme and thermal deactivation; hence there is a decrease in enzyme activity.
Effect of metal ions
Effect of few metal ions was studied according to “Materials and methods”. With the cloned enzyme, not much inhibitory effect was seen on the enzyme activity (Table 2). The activity of control cloned enzyme was similar to the enzyme in the presence of metal ions.
Half-life of asparaginase
The enzyme assay was done and half-life was calculated according to “Materials and methods” at 28 °C (room temperature) and 37 °C (Table 3). Half-life of cloned enzyme was found to be 35 h at 28 °C and 45.5 h at 37 °C.
Discussion
In the present study, we have produced l-asparaginase by cloning the asparaginase gene from Pseudomonas sp. into E. coli, for that we started our work with isolation of DNA, primer designing for asparaginase gene, cloning into pET101 for expression and pTZ57 R/T vector for sequencing, expression of the Asparaginase gene into E. coli BL21, obtaining large quantity of enzyme using 10 L fermenter, purifying the enzyme and finally characterizing the cloned purified Asparaginase was carried out. Recombinant l-asparaginase was developed by cloning l-asparaginase from Erwinia carotovora NCYC 1526 (Er A) and expressing in E. coli. The enzyme was purified by anion-exchange chromatography and affinity chromatography on immobilized asparagine (Kotzia and Labrou 2005). Recombinant l-asparaginase has been produced by the use of molecular cloning and genetic engineering techniques. E. coli mutants resistant to substrate l-asparaginase were studied by Spring et al. (1986). It was found that the genes encoding l-asparaginase-I and l-asparaginase-II were not sequence related.
Cloning of E. coli gene ansB encoding l-asparaginase-II, using strategy based on PCR, and sequencing the gene was discussed by Bonthron (1990). The amino acid sequence differed from 11 positions from the data previously derived by direct amino acid sequencing. Expression of l-asparaginase-II encoded by ansB in Salmonella enterica was found to be positively regulated by a cAMP receptor protein (cRP) and anaerobiosis (Jennings and Beacham 1993). Abundance of AS mRNA was measured by RQ-PCR as reported by Irino et al. (2007), the AS mRNA level paralleled the AS enzyme activity and the AS protein level. Cellular levels of AS synchronized with cellular resistance to l-asparaginase in cell lines. Recombinant l-asparaginase from Erwinia carotovora, and purified by 1-step chromatography, was described by Krasotkina et al. (2004). The kinetic properties showed that recombinant l-asparaginase combined the main advantages of Erwinia chrysanthemi and E. coli l-asparaginase-II. l-asparaginase from Erwinia chrysanthemi 3937 (Erl-ASNase) has been expressed in E. coli BL21 (DE3) pLysS (Kotzia and Labrou 2007). The enzyme was found to be a tetramer with molecular weight of approximately 141 kDa. It had a pH optima at 6.3 and temperature optima of 34 °C with K m of 109.99 mM and V max of 2.88 µM/min. Its activation energies were found to be dependent on the substrate. The l-asparaginase-II functional form exists as tetramer in Pseudomonas geniculate (Kitto et al. 1979) and E. coli (Khushoo et al. 2004) with molecular mass range from 140 to 160 kDa (Aghaiypour et al. 2001, El-Naggar et al. 2014). The l-asparaginase gene of E. coli alpha-acetyl actate decarboxylate gene (ALDC) of B. brevis were amplified by PCR and cloned into a new vector transformed into S. cerevisiae. Most of the enzyme activities were secreted into the medium and the new vectors had excellent segregation stability (Zhao et al. 2002). The enzymatic and structural properties of the recombinant enzyme were investigated and the kinetic parameters [K m, K cat] for a number of substrates were determined. The enzyme was later immobilized on epoxy-activated Sepharose CL-6B as described by Gladilina et al. (2009) who have taken SP-Sepharose (2.5 × 10 cm) equilibrated with 20 mM potassium phosphate buffer, pH 5.8. The immobilized enzyme retained most of its activity (60 %) and showed high stability at 4 °C. l-Asparaginase II gene isolated from thermotolerant E. coli strain, cloned in pET20b vector with 6His residues at a c-terminus downstream to the T7 promoter and pelB leader sequence, and biochemically characterized. Apart from clinical use, this enzyme can be used in fried starchy food preparation to reduce the acrylamide content, a potent carcinogen formed during the baking process by the reaction of asparaginase and sugar at hight temperature (Muharram et al. 2014). Application of microbial Lasparaginase in reducing acrylamide formation during the bread-making process, without affecting its physico-sensory properties and play an important role in reducing the formation of acrylamide. Reduction of toxic metabolites like acrylamide and HMF, i.e., Hydroxymethylfurfural (another toxic Maillard reaction compound) formed during baking, was also reduced by l-asparaginase treatment. The enzyme-treated bread was same as control bread with respect to organoleptic properties. This opens avenues for the application of microbial enzymes in obtaining safe foods (Mohan Kumar et al. 2014).
Cloning of E. coli gene ansB encoding l-asparaginase-II, using strategy based on PCR, and sequencing the gene was discussed by (Bonthron 1990). The amino acid sequence differed from 11 positions from the data previously derived by direct amino acid sequencing. Expression of l-asparaginase-II encoded by ansB in Salmonella enterica was found to be positively regulated by a cAMP receptor protein (cRP) and anaerobiosis (Jennings and Beacham 1993).
Conclusion
The cloned enzyme was studied for its stability at 28 °C (room temperature) and at 37 °C, and it was observed that the cloned Asparaginase was stable with a half-life of 35 h at 28 °C (room temperature) and 45.5 h at 37 °C. Cloned Asparaginase was better in terms of activity and stability at 37 °C. This enzyme could be used/stored for longer time periods at room temperature for experiments relating to acrylamide reduction in food products. Also, its higher half-life at 37 °C makes it a more suitable enzyme to be used against cancerous cells.
References
Aghaeepoor M, Mozafari S, Shahraki MK, Tabandeh F, Bambai B (2011) High level of extracellular fermentation and alternative purification of Escherichia coli asparaginase II. Biharean Biol 5(2):96–101
Aghaiypour K, Wlodawer A, Lubkowski J (2001) Structural basis for the activity and substrate specificity of Erwinia chrysanthemi l-asparaginase. Biochemistry 40:5655–5664
Avramis VI, Panosyan EH (2005) Pharmacokinetic/pharmacodynamic relationships of asparaginase formulations: the past, the present and recommendations for the future. Clin Pharm 44(4):367–393
Bonthron DT (1990) l-asparaginase II of Escherichia coli K-12: cloning, mapping and sequencing of the ansB gene. Gene 91(1):101–105
Bradford M (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein dye binding. Anal Biochem 72:248–254
Ebrahiminezhad A, Rasoul-Amini S, Ghasemi Y (2011) l-Asparaginase production by moderate halophilic bacteria isolated from maharloo salt lake. Indian J Microbiol 51(3):307–311
El-Naggar NE, El-Ewasy SM, El-Shweihy NM (2014) Microbial l-asparaginase as a potential therapeutic agent for the treatment of acute lymphoblastic leukemia: the pros and cons. Int J Pharmacol 10(4):182–199
Gladilina YA, Sokolov NN, Krasotkina JV (2009) Cloning, expression and purification of Helicobacter pylori l-asparaginase. Biochem (Moscow) Supp Ser Biomed Chem 3(1):89–91
Hawkins DS, Park JR, Thomson BG, Felgenhauer JL, Holcenberg JS, Panosyan EH, Avramis VI (2004) Asparaginase pharmacokinetics after intensive polyethylene glycol-conjugated l-asparaginase therapy for children with relapsed acute lymphoblastic leukaemia. Clin Cancer Res 10:5335–5341
Irino K, Vaz TMI, Medeiros MIC, Kato MAMF, Gomes TAT, Vieira MAM, Beatriz EC (2007) Serotype diversity as a drawback in the surveillance of Shiga toxin-producing Escherichia coli infections in Brazil. J Med Microbiol 56(4):565–567
Jennings MP, Beacham IR (1993) Co-dependent positive regulation of the ansB promoter of Escherichia coli by CRP and the FNR protein: a molecular analysis. Mol Microbiol 9(1):155–164
Khushoo A, Pal Y, Singh BN, Mukherjee KJ (2004) Extracellular expression and single step purification of recombinant Escherichia coli l-asparaginase-II. Prot Exp Purif 38:29–36
Kishore V, Gowda KRS, Krishna S, Sharma K, Rashmi M (2014) Bovine serum albumin a potential thermostabilizer: a study on α-amylase. J Appl Environ Microbiol 2:37–41
Kitto GB, Smith G, Thiet TQ, Mason M, Davidson L (1979) Tumor inhibitory and non-tumor inhibitory l-asparaginases from Pseudomonas geniculata. J Bacteriol 137(1):204–212
Kotzia GA, Labrou NE (2005) Cloning, expression and characterisation of Erwinia carotovora l-asparaginase. J Biotech 119(4):309–323
Kotzia GA, Labrou NE (2007) l-Asparaginase from Erwinia chrysanthemi 3937: cloning, expression and characterization. J Biotech 127(4):657–669
Krasotkina J, Borisova AA, Gervaziev YV, Nikolay N (2004) One-step purification and kinetic properties of the recombinant l-asparaginase from Erwinia carotovora. Biotechnol Appl Biochem 39:215–221
Lee SM, Wroble MH, Ross JT (1989) l-Asparaginase from Erwinia carotovora: an improved recovery and purification process using affinity chromatography. Appl Biochem Biotechnol 22:1–11
Lineweaver H, Burk V (1934) The determination of enzyme dissociation constants. J Am Chem Soc 56(3):658–666
Mohan Kumar NS, Crassina AS, Indrani D, Manonmani HK (2014) Reduction of acrylamide formation in sweet bread with l-asparaginase treatment. Food Bioprocess Technol 7:741–748
Muharram MM, Abdulhamd AT, Mounir M (2014) Recombinant expression, purification of l-asparaginase-II from thermotolerant E. coli strain and evaluation of its antiproliferative activity. African J Microbiol Res 8(15):1610–1619
Oza VP, Parmar PP, Patel DH, Subramanian RB (2011) Cloning, expression and characterization of l-asparaginase from Withania somnifera L. for large scale production. 3. Biotech 1(1):21–26
Ramakrishnan MS, Joseph R (1996) Characterization of an extracellular asparaginase of Rhodosporidium toruloides CBS14 exhibiting unique physicochemical properties. Canadian J Microbiol 42(4):316–325
Spring KJ, Jerlstrom PG, Burns DM, Beacham IR (1986) l-Asparaginase genes in Escherichia coli: isolation of mutants and characterization of the ansA gene and its protein product. J Bacteriol 166:135–142
Zhao Y, Liang S, Huang K, Huang R (2002) Construction of a set of secreting expression vectors for Saccharomyces cerevisiae. Weishengwu Xuebao 42(2):431–435
Acknowledgments
The authors like to acknowledge the Head of Department, Fermentation technology and Bio-engineering Department and Director of CFTRI, Mysore for their continuous support for the research.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
About this article
Cite this article
Kishore, V., Nishita, K.P. & Manonmani, H.K. Cloning, expression and characterization of l-asparaginase from Pseudomonas fluorescens for large scale production in E. coli BL21. 3 Biotech 5, 975–981 (2015). https://doi.org/10.1007/s13205-015-0300-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13205-015-0300-y